Extrait

The primary efficacy objective of the study is to evaluate the effect of IV iron isomaltoside 1000 compared with placebo in first-time female donors with p-ferritin below 60 µg/L. The safety objective of the study is to evaluate the safety of IV iron isomaltoside 1000 compared to placebo.

Critère d'inclusion

• Female first-time bloddonors with iron deficiency

Liens

• ictrp
• euctr